SCHEMBL2836619

SCHEMBL2836619

C/C=C1\CC(C(=O)OC)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.49
NR1H2 P55055 2/20 0.39
NR1H3 Q13133 1/20 0.39
MMP2 P08253 1/20 0.35
ANPEP P15144 1/20 0.35
CYP19A1 P11511 1/20 0.35
NPC1 O15118 1/20 0.34
PDE4B Q07343 1/20 0.34
HDAC8 Q9BY41 2/20 0.34
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
IMPDH2 P12268 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2380958 1.00 PTPN1 (0.49) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL30987621 1.00 PTPN1 (0.49) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL2380961 1.00 PTPN1 (0.49) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL14915162 0.89 PTPN1 (0.49) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL21845196 0.89 PTPN1 (0.49) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL14915166 0.89 PTPN1 (0.49) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL14915165 0.89 PTPN1 (0.49) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL31239774 0.87 PTPN1 (0.48) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL31000507 0.86 PTPN1 (0.47) PTPN1NR1H2NR1H3MMP2ANPEP
SCHEMBL29851000 0.86 PTPN1 (0.47) PTPN1NR1H2NR1H3MMP2ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 WO disclosed
WO-2010062821-A1 ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE GLAXOSMITHKLINE LLC (US) 2010-06-03 WO disclosed